feed,title,long_url,short_url
GN:S:RL,Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders USA - English - USA - English - PR Newswire,https://www.prnewswire.com/news-releases/insilico-medicine-announces-advancement-of-its-preclinical-candidate-for-usp1-synthetic-lethality-target-to-ind-enabling-studies-for-various-oncological-disorders-301524925.html,https://prn.to/36dF58U
